Bicara Therapeutics Inc（BCAX）の株価予測BCAXBicara Therapeutics Inc

Alphio's BCAX stock price prediction model matches the current Bicara Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.90 (+1.59%). The 1-week path is $18.22 (+3.43%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Bicara Therapeutics Inc is currently not a strong buy due to its recent performance and financial losses, despite a potential upside reflected in analyst price targets. The current price is $17.50, with a forward P/E of 0, indicating no earnings expected in the near term. The RSI is at 38.166, suggesting the stock is nearing oversold territory, but the company reported a net loss of $56.2 million in Q1 2026, which raises concerns about its financial health. While analysts have set price targets as high as $39, the significant losses and management changes create uncertainty, warranting a hold recommendation for now.

Bicara Therapeutics Inc (BCAX) last closed at $17.62, gaining +1.61%. These facts feed the 1-day and 1-week BCAX price prediction above.